Bolt Biotherapeutics appoints Nicole Onetto to board; Ashish Khanna resigns

Bolt Biotherapeutics, Inc.

Ashish Khanna resigned from Bolt board and its Audit and Compensation committees effective Dec 13, 2021; no disagreement.
Nicole Onetto appointed as Class III director effective Dec 14, 2021; term expires at 2024 annual meeting.
Dr. Onetto received initial option grant of 27,860 shares vesting over 36 months and annual grant of 13,930 shares.
She also receives $35,000 annual cash retainer and standard indemnification; Board determined she is independent.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nicole Onetto

Director

BOLT · Bolt Biotherapeutics, Inc.

Effective: 2021-12-14
Filed: December 16, 2021, 6:59 PM ET

On December 14, 2021, upon recommendation of the Nominating and Corporate Governance Committee, the Board appointed Nicole Onetto to the Board as a Class III director of the Company, effective immediately, to fill the vacancy on the Board.

Departed

Ashish Khanna

Director

BOLT · Bolt Biotherapeutics, Inc.

Effective: 2021-12-13
Filed: December 16, 2021, 6:59 PM ET

On December 13, 2021, Ashish Khanna, a director of Bolt Biotherapeutics, Inc. (the “Company”) resigned as a member of the Company’s Board of Directors (the “Board”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole Onetto was appointed as Director at Bolt Biotherapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

On December 14, 2021, upon recommendation of the Nominating and Corporate Governance Committee, the Board appointed Nicole Onetto to the Board as a Class III director of the Company, effective immediately, to fill the vacancy on the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ashish Khanna resigned as Director at Bolt Biotherapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 13, 2021, Ashish Khanna, a director of Bolt Biotherapeutics, Inc. (the “Company”) resigned as a member of the Company’s Board of Directors (the “Board”), effective immediately.

View on SEC.gov

Bolt Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-21-060502

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.